Novo Nordisk, maker of Ozempic, unseats LVMH as European stock

Ozempic-maker Novo Nordisk becomes biggest company in Europe amid worldwide scramble for 'miracle' weight-loss drug - ABC News

Ozempic-maker Novo Nordisk briefly becomes Europe's most valuable firm

Novo Nordisk surpasses LVMH and becomes Europe's most valuable listed company — MedWatch

Novo Nordisk owner sees IPO window opening

Novo Nordisk Competes With LVMH to Be Europe's Most Valuable Firm

Novo Nordisk briefly eclipses LVMH as Europe's most valuable company

CHART OF THE DAY: Ozempic Maker Novo Nordisk Is Biggest Company in Europe

Ozempic, Wegov: Weight Loss Drug Demand Boosts Novo Nordisk Stock - Bloomberg

Novo Nordisk owner readies for big Wegovy windfall

Novo Nordisk launches weight loss injection Wegovy in UK, company says 'closely monitoring demand

Wegovy makes UK weight-loss debut even as Novo struggles with supplies

Novo Nordisk Becomes Europe's Most Valuable Company

Novo Nordisk briefly overtakes LVMH in European ranking

Signal: Novo Nordisk market cap higher than Danish GDP due to obesity drugs - Pharmaceutical Technology

CHART OF THE DAY: Ozempic maker Novo Nordisk overtakes LVMH to become the biggest company in Europe